Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
530.00    5.00 (0.95%)
Bid:
530.00
Ask:
534.00
Spread: 4.00 (0.755%)
Market Cap: £304.98m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

26 May 2020 07:00

RNS Number : 8362N
Mortgage Advice Bureau(Holdings)PLC
26 May 2020
 

26 May 2020

Mortgage Advice Bureau (Holdings) plc

AGM Statement

Mortgage Advice Bureau (Holdings) plc ("MAB"), one of the UK's leading consumer intermediary brands and specialist Appointed Representative ("AR") networks, will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"Adviser numbers have remained stable since our final results announcement on 23 April 2020. As at 22 May 2020, our number of advisers totalled 1,476, including 215 furloughed advisers.

Amid a relaxation of the lockdown announced by the UK Government, the housing market re-opened in England on 13 May 2020 with new regulations enabling surveyors to undertake physical valuations and property appraisals and buyers to visit properties and arrange removals, subject to a new set of safety guidelines. This signals the start of a gradual recovery of the housing market, despite some remaining loan to value constraints. Restrictions on the housing market in Wales, Northern Ireland and Scotland remain in place but are expected to be lifted shortly.

After a strong first quarter followed by two months of significant reduction in purchase-related activity under lockdown, we expect our growth to start resuming progressively as advisers come out of furlough and purchase related productivity starts to build.

During this challenging period, our advisers have turned their focus towards opportunities in the re-mortgage, product transfer and protection markets. We have prioritised our resources to support advisers in these areas and ensure the improvements we have seen as a result are maintained and built upon as purchase transaction volumes start to recover.

The attitude, hard work and dedication of the MAB team during this unprecedented time has been exceptional, and as a result MAB's support for its ARs and their customers is standing out more than ever in this market.

Over 40 new campaigns and initiatives have been rolled out or piloted in the last 10 weeks alone, and we have been delighted with how our AR firms and their advisers have responded. They have embraced new ways of engaging remotely with customers, making more of every opportunity as well as ensuring their customers are properly looked after during these challenging times.

Whilst the outlook will no doubt remain uncertain for some time, we have already seen increased activity since the re-opening of the English house purchase market, which we expect will gather pace over the coming weeks and months.

Additionally, we believe that the new ways of working and initiatives we have implemented to support our ARs in maximising lead generation in the re-mortgage, product transfer and protection markets will strengthen their future performance as well as assist with new AR recruitment. We therefore remain very positive about the future."

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: 

Numis Securities Limited Tel: +44 (0)20 7260 1000

Stephen Westgate / Hugo Rubinstein (Corporate Finance)

 

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKKPBKDBKBQPB
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.